Delivery Order SPE2DB20D9214-SPE2DB24FD4VS

Award Date 8/2/24
Potential Completion Date 8/23/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,126.98 firm fixed-price delivery order is for the supply of YF-VAX 1 dose vials, with a period of performance running through September 16, 2024. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB...
This federal contract award, valued at $47,274.40, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of YF-VAX 1 dose vials, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. The contract is a firm fixed-price delivery order and does not have a set-aside designation. It is associated with a...
This federal contract award, valued at $2,226.84, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of YF-VAX 1 dose vials, a specialized pharmaceutical product. The contract is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program....
This federal contract award, valued at $3,380.94, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of YF-VAX 1 dose vials, a vaccine product. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. Through this IDC,...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $5,567.10 for the supply of YF-VAX 1 dose vials. The award is not associated with a set-aside designation. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,690.47, is for the delivery of YF-VAX 1 dose vials. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a wide...
This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,634.90 firm fixed-price delivery order contract is for the supply of YF-VAX 1 dose vials, with a period of performance through August 19, 2024. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS...
The federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,034.80 firm fixed-price delivery order is for the supply of YF-VAX 1 dose vials, with a completion date of February 4, 2022. This award is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,126.98 firm fixed-price delivery order is for the supply of YF-VAX 1 dose vials, with a performance period ending on August 28, 2024. This award is issued under a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA's Medical Supply Chain division....
This federal contract award, valued at $26,591.85, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, a firm fixed-price delivery order, is for the supply of YF-VAX 1 dose vials, a vaccine product. This award is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, valued up to $499,999,999, which...
  • SPE2DB20D9214
    Indefinite Delivery Contract
  • SPE2DB20D9214-SPE2DB24FD4VS
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with a ceiling value of $2,253.96, is for the delivery of YF-VAX 1 dose vials to support the recurring medical supply needs of military health facilities worldwide.

This contract is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program. The IDC allows the DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical products, from common medications to specialized drugs and medical supplies, to fulfill the diverse medical requirements of Department of Defense healthcare facilities globally. This contract has no set-aside designation.

Generated 11/1/24, 9:32 AM